U-Blot® Research Grade VolociximabCat. No. WA3796Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade VolociximabCat. No. WA3796U-Blot® Research Grade VolagidemabCat. No. WA3795Request quote
Size: 50ug/100ug
U-Blot® Research Grade VofatamabCat. No. WA3794Request quote
Size: 50ug/100ug
U-Blot® Research Grade VobramitamabCat. No. WA3793Request quote
Size: 50ug/100ug
U-Blot® Research Grade VobarilizumabCat. No. WA3792Request quote
Size: 50ug/100ug
U-Blot® Research Grade VixtimotamabCat. No. WA3791Request quote
Size: 50ug/100ug
U-Blot® Research Grade VixticibartCat. No. WA3790Request quote
Size: 50ug/100ug
U-Blot® Research Grade VixarelimabCat. No. WA3789Request quote
Size: 50ug/100ug
U-Blot® Research Grade VisugromabCat. No. WA3788Request quote
Size: 50ug/100ug
U-Blot® Research Grade Vislarafusp AlfaCat. No. WA3787Request quote
Size: 50ug/100ug
U-Blot® Research Grade VisilizumabCat. No. WA3786Request quote
Size: 50ug/100ug
U-Blot® Research Grade VIR-2482Cat. No. WA3785Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
FAX+(1)-866-986-9598